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Numerous mammal species, including domestic and wild animals such as ruminants, dogs, cats and rodents, as
well as humans, serve as reservoir hosts for various Bartonella species. Some of those species that exploit non-
human mammals as reservoir hosts have zoonotic potential. Our understanding of interactions between bartonellae
and reservoir hosts has been greatly improved by the development of animal models for infection and the use of
molecular tools allowing large scale mutagenesis of Bartonella species. By reviewing and combining the results of
these and other approaches we can obtain a comprehensive insight into the molecular interactions that underlie
the exploitation of reservoir hosts by Bartonella species, particularly the well-studied interactions with vascular
endothelial cells and erythrocytes.Table of contents
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Bartonella species are small, curved, pleomorphic, fastidi-
ous, haemotropic Gram-negative bacteria that have specif-
ically adapted to infect mammals. Although 26 Bartonella* Correspondence: mvayssier@vet-alfort.fr
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reproduction in any medium, provided the orspecies or sub-species have been formally validated to
date, many more, as yet partially characterized, await for-
mal proposal. Bartonellae have been encountered in mam-
mals all over the world, however the prevalence of
infections and their public health and veterinary import-
ance vary according to species and geographical region.
Bartonella species are transmitted between mammalian
hosts by blood-feeding arthropods. Numerous, diverse
arthropods have been implicated in the transmission of
bartonellae, but each Bartonella species appears to exploit
only one, or few, arthropod species. The role of arthropods
in the natural cycle of bartonellae may extend beyond
mere vectors; there is some evidence to support their role
as additional reservoirs for the bacteria. Each Bartonella
species also appears to be highly adapted to one or few
mammalian reservoir hosts [1,2] in which they establish a
long-lasting intra-erythrocytic bacteraemia as the hallmark
of infection [3]. This bacteraemia does not appear to cause
immediate detriment to the host. In general, bartonellae
provoke acute clinical manifestations only when acciden-
tally introduced into the wrong host or when encounter-
ing immunocompromised individuals among reservoir
populations.
The Bartonella genus lies among the alpha proteobac-
teria in proximity to the genus Brucella. Both genera are
classified in the family Rhizobiales that also embraces a
large number of taxa of plant-associated and environmentaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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described to date, with one species, Bartonella vinsonii,
subdivided into three subspecies (Table 1). Inference of the
phylogenetic relationships within the genus reveals the pro-
found divergence of Bartonella bacilliformis, which lies
alone on an “ancient” ancestral lineage (lineage 1), apart
from the other Bartonella species. The remaining “mod-
ern” species form two further lineages, with lineage 2
containing the four ruminant-associated species (Barto-
nella bovis, Bartonella capreoli, Bartonella chomelii and
Bartonella schoenbuchensis), and lineage 3 containing the
remaining 19 species (Figure 1). Within lineage 3, Barto-
nella clarridgeiae is the outlier, and phylogenetic studies
that have also included as yet only partially characterised
bartonellae have suggested that this species is a represen-
tative of a fourth lineage within the genus [4,5]. The
complete genome sequences of six Bartonella species (B.
bacilliformis, B.clarridgeiae, Bartonella grahamii, Barto-
nella henselae, Bartonella quintana and Bartonella tribo-
corum) have been published to date, although efforts toTable 1 Validated Bartonella species, their reservoir hosts, an
Bartonella species Proven/suspected res
B.alsatica rabbits
B. bacilliformis humans






B. doshiae small rodents
B. elizabethae rats
B. grahamii small rodents
B. henselae felids







B. silvatica small rodents
B. talpae moles
B. taylorii small rodents
B. tribocorum rats
B. vinsonii subsp. arupensis small rodents
B. vinsonii subsp. berkhoffii canids
B. vinsonii subsp. vinsonii small rodentssequence the genomes of all remaining species and nu-
merous partially-characterised bartonellae are also under-
way. The sizes of the published genomes range from
1.45 Mb to 2.62 Mb [4,6].
B. bacilliformis and B. quintana are the two Bartonella
species that appear to exploit humans as reservoir hosts
(Table 1). Infections with B. bacilliformis only occur in
the Andean region of South America [7,8], and this geo-
graphical distribution correlates with the range of the
Lutzomyia species that are thought to transmit infec-
tions [8]. B. bacilliformis appears to be potentially the
most pathogenic Bartonella species, provoking a re-
markably bi-phasic disease referred to as bartonellosis.
Acute bartonellosis manifests as Oroya fever, a disease
which is characterized by a severe haemolytic anaemia
effecting, in some cases, nearly 100% of erythrocytes. Fa-
tality rates of up to 80% have been described in patients
not receiving antibiotic treatment [9]. B. bacilliformis
infections can also manifest as verruga peruana, charac-
terized by vascular tumours that result from the massived their currently perceived medical relevance













Figure 1 Molecular phylogenetic analysis of the 24 extant, validated Bartonella taxa inferred from alignment of partial (326 bp) gltA
sequences. Evolutionary history was inferred by using the Maximum Likelihood method based on the Tamura-Nei model. The tress with the
highest log likelihood is shown. Evolutionary analyses were conducted in MEGA5. Imposed on the tree are the distributions of the three T4SSs
(red box = VirB/D4, blue box= Trw, green box: Vbh) and flagella (orange box) amongst the taxa. To the right of the tree is an indication of the
three evolutionary lineages defined within the genus.
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for more than one year [7,8]. Verruga peruana was prob-
ably recognized during pre-Columbian times, but its
aetiology was not resolved until 1905, when B. bacillifor-
mis was first isolated. B. quintana infections were first
recognized during World War I in the form of trench
fever (or five-day fever), but the bacterium was not iso-
lated until 1961. Medical interest in B. quintana waned
after World War II as infections became rare, but, at the
end of the twentieth century, B. quintana re-emerged as
a bacterium of public health importance with recogni-
tion of its role in persistent bacteraemia in the homeless,
drug and alcohol addicts (“urban” trench fever) and refu-
gees. Infection is usually characterized by a chronic
intra-erythrocytic bacteraemia with few, mild, self-
limiting symptoms [10], although more severe manifes-
tations such as endocarditis and bacillary angiomatosis
have also been reported [10]. B. quintana is transmitted
by the human body louse (Pediculus humanus huma-
nus), an ectoparasite that is specific to humans but
which only emerges when clothes remain unchanged
and unwashed [11]. Thus, as with B. bacilliformis, vector
behaviour is a key determinant in the epidemiology of B.
quintana infections.Numerous domestic and wild animals, including rumi-
nants, felids, canids and rodents serve as reservoir hosts
for various Bartonella species (Table 1) [2]. To date, evi-
dence of zoonotic potential has been reported for 10 of
these species (Table 1). In these reports, no evidence of
an intra-erythrocytic presence of zoonotic bartonellae in
infected humans has been reported [12]. Of the
zoonosis-associated Bartonella species, B. henselae is the
most frequently associated with human disease. B. hense-
lae exploits felids, including domestic cats as reservoir
hosts, between which infection is transmitted by cat fleas
(Ctenocephalides felis) [13]. As is typical for reservoir
hosts, cats usually do not develop any apparent symp-
toms of infection, which can persist for months or years
[14]. B. henselae transmission from cats to humans is
thought to occur primarily by the inoculation of infected
flea faeces via cat scratches or bites [13], although there
is also some evidence that infection can be acquired
from ticks [15,16]. B. henselae can provoke a wide var-
iety of clinical manifestations in humans, including,
most commonly, lymphadenopathy (cat scratch disease),
malaise, fever and splenomegaly that can persist for sev-
eral months. Less frequently (< 25% of cases) [17], more
serious manifestations can occur, including angiomatosis
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cephalitis, meningitis, glomerulonephritis and endocar-
ditis [12].
The other nine zoonosis-associated Bartonella species
exploit a range of reservoir hosts; for example, B. vinso-
nii subspecies berkhoffii parasitizes canids (domestic
dogs, coyotes and gray foxes) and Bartonella alsatica
parasitizes rabbits. Others, such as B. grahamii are asso-
ciated with woodland rodents (Table 1). In addition to
their potential as human pathogens, numerous Barto-
nella species have been implicated in veterinary infec-
tious diseases, including, most frequently, B. henselae
and B. vinsonii subspecies berkhoffii. Many of the mani-
festations observed in cats and dogs are akin to those
observed in humans.
Dynamics of infection in mammalian reservoir
hosts
The life cycle of bartonellae in their reservoir hosts has
been deduced through observations of naturally infected
mammals and through experimental infections. In a
seminal study [3], the evolution of infection of B.tribo-
corum in laboratory rats was monitored using a green
fluorescent protein (GFP)-tagged bacterial strain in con-
junction with microscopy and flow cytometry. This
study found that, following intravenous injection (mod-
els incorporating a natural route of infection still remain
generally elusive), bacteria could be initially detected in
the blood but were soon cleared, only to reappear again
between two and five days later. Only on reappearance
were bartonellae observed inside erythrocytes, although
only a small proportion of erythrocytes were infected.
Erythrocytes were usually invaded by a single bacterium,
which, once inside, replicated in a membrane-bound
compartment over a period of several days until, on
average, eight daughter cells were created. Replication
then ceased and infected erythrocytes were shown to
persist in circulation for several weeks. This process did
not provoke symptoms in the infected rat [3]. Experi-
ments using other animal models, such as a B. birtlesii-
mouse model [18-20], and a B. henselae-cat model [21]
have yielded results that are akin to those observed in
the B. tribocorum-rat model, suggesting a common
infection mode for all Bartonella species in their
respective animal reservoirs [22]. Furthermore, the kin-
etics of bacteraemia observed in these models were simi-
lar to those observed in captured naturally-infected
animals (unpublished observations), which supports the
reliability of results obtained from artificial routes of
inoculation.
Our understanding of bartonellae/host interactions
has been greatly improved by the development of mo-
lecular tools allowing large scale mutagenesis of Barto-
nella species such as B. tribocorum and B. birtlesii. Theuse of these tools in conjunction with judicious screen-
ing in relevant animal models (rats and mice respect-
ively) has resulted in the identification of numerous
genetic sequences, the integrity of which are necessary
for the establishment of bacteraemia by bartonellae
[4,19]. Those genetic sequences can be classified into six
groups: (1) genes previously implicated in Bartonella in-
fection of its mammalian hosts, (2) genes encoding cell
envelope components, (3) genes encoding proteins
involved in metabolism, (4) phage-related genes, (5)
genes encoding proteins of unknown function and (6)
intergenic regions. These data, when combined with the
results of in vitro studies, allow us to piece together an
overview of the molecular basis of reservoir host exploit-
ation by Bartonella species.
Step 1: Infection prior to bacteraemia
As mentioned above, inoculation of a susceptible host
appears to be primarily mediated by the introduction of
infected vector faeces into cuts or scratches on the skin.
However, the fate of infecting bacteria immediately fol-
lowing inoculation, prior to their appearance in the
bloodstream, remains uncertain. Nonetheless, it is clear
that bartonellae can colonise highly vascularised tissues
like the liver and spleen during the first days of infec-
tion, as well as the vascular bed of the skin (for B. bacil-
liformis) [23]. A current opinion is that the vascular
endotheliature serves as a primary niche for bartonellae.
Indeed, bartonellae have been shown to have the ability
to induce vasoproliferation, manifesting as verruga per-
uana (B. bacilliformis) or bacillary angiomatosis/peliosis
hepatis (B. henselae and B. quintana). In many in vitro
studies, bartonellae have been shown to be able to in-
vade endothelial cell lines and/or interfere with their
physiology [24-28] (see below). However, although the
endothelial vasculature undeniably plays a role in the
early stages of infection, there is some experimental evi-
dence that other putative cell types, such as erythrocytic
precursors, may also serve as a niche for infecting barto-
nellae [29]. This hypothesis, however, conflicts with data
obtained using the GFP-B. tribocorum-rat model that
clearly indicated that encounter with, and invasion of,
erythrocytes occurs in the bloodstream [3]. Furthermore,
we have been unable to find any evidence for the pres-
ence of bartonellae in erythrocyte precursors isolated
from the bone marrow of B. birtlesii-infected mice, des-
pite rigorous efforts to do so (unpublished observations).
It should also be borne in mind that evidence for vascu-
lar endothelial cell involvement in vivo is drawn primarily
from pathological observations of B. bacilliformis-induced
verruga peruana, and bacillary angiomatosis, a rare mani-
festation of B. henselae and B. quintana infections of
humans. Endothelial cell colonisation has not yet been
reported in asymptomatically infected reservoir hosts.
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lesions that characterise verruga peruana and bacillary
angiomatosis suggests bartonellae are rather concentrated
in proximity to the external surface of the endothelial
cells, rather than within them. Thus, although we devote
much of this review to the molecular basis of bartonellae-
vascular endothelial cell interactions, we do not discount
the possibility that an as yet unidentified alternative pri-
mary niche may exist.
Exploitation of vascular endothelial cells by bartonellae
involves binding to the cell surface, possible internalisa-
tion, then persistence within (or adjacent to) cells. To
date, two major bacterial factors that play crucial roles
in interacting with endothelial cells have been identified,
namely the BadA/Vomp/Brp proteins and the VirB/D4
type four secretion system (T4SS) and its effectors.
Other bacterial surface proteins, including the haem-
binding protein A (Pap31) and Omp43, have also been
shown to interact with these cells. All of these factors
have also been shown to be essential for the establish-
ment of bacteraemia, as revealed by signature-tagged
mutagenesis (STM) screening in both B. birtlesii-mouse
and B. tribocorum-rat infection models, underlying the
notion that bacteraemia is not the initial stage of the in-
fection process.
The badA/vomp/brp adhesions
These proteins have different names in different Barto-
nella species, reflecting their concurrent discovery by in-
dependent groups of researchers. These proteins are
referred to as bartonella adhesin A (BadA) in B. henselae
[30], the variably-expressed outer membrane proteins
(Vomps) in B. quintana [31], and bartonella repetitive
protein A (BrpA) in B. vinsonii [32]. They are outer mem-
brane proteins belonging to the trimeric autotransporter
adhesin (TAA) family [33], that also includes the yersinia
adhesin A (YadA) in Yersinia enterocolitica [34], the Hae-
mophilus influenzae adhesin (Hia) as well as the haemo-
philus surface fibrils (Hsf) in H. influenzae [35], and the
ubiquitous surface protein A (UspA) in Moraxella catar-
rhalis [36], all of which are considered to be virulence fac-
tors. All TAA family members share similar modular
architectures, consisting of a head, neck, stalk, and C-
membrane anchor domains [34]. The C-membrane an-
chor domains define the TAA family and form trimers
[37,38]. The size of these proteins varies from one species
to another due to the number of TAA neck/stalk repeats,
which can differ by up to four-fold. In B. henselae, the
monomeric form of Bad A is 328kDa in size [30]. In B.
quintana, Vomps are encoded by a family of four genes,
three of which are very similar to badA (the exception
being vompD). Although BrpA remains little studied, the
functions of BadA and Vomp have been extensively
explored using in vitro assays and experimental animalmodels. This work has demonstrated the pleiotropy of
these proteins, implicating them in (1) mediation of bind-
ing of bartonellae to extracellular matrix proteins (col-
lagens and fibronectin) and to endothelial cells, via α-5β-
1-integrins (2) circumvention of phagocytosis (3) medi-
ation of angiogenesis via activation of hypoxia-inducible
factor 1 (the key transcription factor in angiogenesis) in
infected endothelial cells and via provocation of secretion
of proangiogenic cytokines (e.g. vascular endothelial
growth factor) [30,39]. BadA/Vomps are also involved in
bacterial auto-aggregation [31,40], and probably in biofilm
formation [41]. Interestingly, there is a marked variation
in the expression of BadA between different B. henselae
strains [42] and it is known that multiple in vitro passage
of isolates results in the loss of BadA expression. Different
genetic processes, such as single base deletions or inser-
tions, or recombination events, can affect BadA expression
resulting in the coexistence of phase variants expressing
or not expressing BadA. This characteristic, when coupled
with the observation that BadA-expressing strains grow
slower than non-expressing strains, suggests that expres-
sion of BadA (which is an enormous molecule) is an ex-
tremely energetic process, and one which bartonellae will
only continue whilst required to do so.
The VirB/D4 T4SS and its effector proteins
T4SSs consist of a multiprotein channel spanning inner
and outer Gram-negative bacteria membranes and a sur-
face filament extending from the bacterial envelope. The
system mediates the transfer of protein or DNA sub-
strates from a bacterial donor cell into various cell types
(e.g. transfer of DNA into other bacteria by conjugation
or transfer of bacterial effector molecules into eukaryotic
cells). In pathogenic bacteria, this protein complex can
be compared to a microscopic syringe that is used to in-
ject effector proteins into target cells in order to subvert
their physiology. T4SSs serve as key virulence factors for
many important human pathogens including Helicobac-
ter pylori, Legionella pneumophila, Bordetella pertussis,
and Brucella melitensis [43]. Akin to other T4SSs, VirB/
D4 is a macromolecular complex of at least 10 compo-
nents termed VirB2 to VirB11 and an associated sub-
strate recognition receptor known as the T4 coupling
protein (T4CP), named VirD4 (Figure 2).
The VirB/D4 T4SS was first identified in Bartonella spe-
cies in 2000 as a result of characterization of the locus that
encodes a 17kDa immunodominant protein in B. henselae
[44]. Genetic comparison of this locus revealed that the
17kDa protein it encoded was a VirB5 homolog and fur-
ther exploration of the locus revealed the presence of
homologs of other members of the T4SS upstream and
downstream of VirB5 [44,45]. The putative promoter re-
gion of the operon was also identified and its expression
was shown to be induced when B. henselae was cultivated
Figure 2 Hypothetical models of the architectures of the VirB/D4 and Trw T4SS, the VirB/D4 system possesses an inner membrane
protein VirD4, the T4CP. External to the outer membrane, VirB4 and VirB11 energize the secretion process. VirB3, 6, 8, 9 and 10 are thought to
form a secretion channel bridging the inner membrane and the surface exposed pilus associated components VirB2 and VirB5. The Bep proteins
are secreted via this system. Trw has a similar structure to VirB/D4, with homologs for all VirB proteins except VirD4, which Trw lacks. Unlike VirB/
D4, Trw expresses multiple variant copies of TrwL and TrwJ. Abbreviations: EX: extracellular matrix, OM: outer membrane, PP: periplasm, IM: inner
membrane, CY: cytoplasm.
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eron was subsequently identified in other Bartonella
species, and its necessity for host interaction was demon-
strated using a B. tribocorum-rat and subsequently a B.
birtlesii-mouse infection model [4,19,47]. Experimentation
using these models revealed that although the VirB/D4
system was essential for exploitation of the primary niche,
it was dispensable for the subsequent erythrocytic infec-
tion [48]. Recent studies have characterised seven genes
encoding for effector proteins, termed bartonella effector
proteins (Beps) A-G that are translocated by the VirB/D4
into endothelial cells [49] and are responsible for subvert-
ing their physiology. Indeed, in vitro experiments have
indicated that VirB/D4 and its effector proteins mediate a
range of profound changes to parasitised endothelial cells
[50,51], including (i) massive rearrangements of the actin
cytoskeleton, resulting in the formation and internalisation
of large bacterial aggregates by a unique “invasome” struc-
ture, (ii) NF-κβ-dependent pro-inflammatory activation
leading to cell adhesion molecule expression and chemo-
kine secretion, and (iii) inhibition of apoptotic cell death
resulting in enhanced endothelial cell survival. Internalisa-
tion of bartonellae via invasomes (characterised by the for-
mation of a bacterial aggregate on the cell surface, which
is subsequently engulfed and internalised by an actin-
dependant mechanisms [26]) is dependent on three VirB/
D4 effectors, BepC, BepG, and BepF [52,53]. BepA has
been shown to inhibit endothelial cell apoptosis through
upregulation of cAMP levels in the cytosol [49] and it also
promotes capillary sprout formation in an endothelial
spheroid infection model, whereas BepG inhibits such
sprouting [54]. The functions of BepB, BepD and BepE are
still to be elucidated. VirB/D4 appears to be part of the
regulon of the BatR/S two component regulatory system,
a global regulator that may be a key mediator of thephysiological transition of bartonellae as they associate
with endothelial cells [55].
A homolog of the VirB/D4 system, Vbh, has also been
identified and all Bartonella species except B. bacillifor-
mis possess at least one of these two T4SSs [4]. Com-
parative genomics have indicated that these systems
were acquired by a common ancestor of lineage 2 and 3
Bartonella species following its divergence from lineage
1 that carries B. bacilliformis (Figure 1) [5]. Given the
key roles attributed to these T4SSs, it is clear that its ac-
quisition has resulted in fundamentally different bases of
host exploitation by B. bacilliformis and the other Barto-
nella species. It has been proposed that species posses-
sing the VirB/D4 or Vbh systems have attenuated
virulence compared to B. bacilliformis, although this
view remains controversial. Indeed, given that VirB/D4
and Vbh are so important for endothelial cell interaction
in all Bartonella species, it is intriguing that the species
in which it is absent, B. bacilliformis, is the species for
which in vivo endothelial cell subversion is the most
apparent.
Other bartonellae proteins have been shown to inter-
act directly or indirectly with endothelial cells or the
extracellular matrix. For instance, the outer membrane
lipoprotein Omp43 is one of the bacterial proteins that
binds most strongly to human umbilical vein endothelial
cells (HUVEC) [56,57]. The Pap31 protein (haem-bind-
ing protein A) of B. henselae binds to fibronectin and
promotes bacterial adhesion to endothelial cells [58]. As
for VirB/D4 and Bad/Vomp, the disruption of these
genes in the genomes of both B. birtlesii and B. tribo-
corum results in the non-appearance of bacteraemia in
inoculated animal models [4,19]. Remarkably, Bartonella
species also appear to secrete the heat-shock protein
GroEL, which is a potent mitogen of HUVECs [59]. A
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factors is schematically represented in Figure 3.
Step 2: Seeding of blood and extra cellular
survival
In various animal models of infection, bacteraemia appears
between 2 and 7 days post infection. It has been proposed
that the appearance of bartonellae in the blood is orche-
strated, occurring in the form of repeated, discreet waves
rather than in a continuous stream [3]. Initially, the bac-
teria are extracellular, thus their passage must present
them with a significant challenge in that they are fully
exposed to the host immune system. Recently, we have
shown that a B. birtlesii badA-knockout (ΔbadA) mutant
was sensitive to mouse serum, while the wildtype B. birtle-
sii, expressing active BadA, was resistant (Figure 4a). Since
the ΔbadA mutant was not killed by heat-inactivated
serum (Figure 4b), we suspect that B. birtlesii BadA is
involved in resistance to complement. In support of this
hypothesis, we show that when wildtype B. birtlesii is
grown in liquid media, the supernatant of this medium
has anti-complement activity, but that this activity can be
neutralized with anti-BadA antibodies (kindly provided by
Professor Volkard Kempf, Goethe-Universität, Frankfurt
am Main, Germany). These observations suggest thatFigure 3 Holistic view of bartonellae interactions with endothelial cel
bartonellae involves binding to the cell surface via BadA/Vomps proteins a
D4 and its effectors mediate massive rearrangements of the actin cytoskele
invasome structure as well as inhibition of apoptosis leading to enhanced
spp. from endothelial cells to erythrocytes is unknown however, it appears
Adherence to erythrocytes appears to be mediated by Trw (for most Barto
species). A erythrocyte is usually infected by a single bacterium, which onc
throughout the lifespan of the red blood cell. During this process, protease
protect bacteria against stress.BadA, or a part of BadA, could be secreted or released by
B. birtlesii to counter the effects of complement, in a man-
ner akin to that reported for the BadA homolog YadA in
Yersinia enterocolitica [60]. We have also obtained evi-
dence that bartonellae are capable of binding IgG Fc frag-
ments and hypothesize that by doing so, the bacteria
further facilitate their extracellular longevity by subversion
of host humoral response. We observed that several Bar-
tonella species had the capacity to bind Fc, and most
could bind immunoglobins derived from a range of differ-
ent mammals. Far-Western blotting indicates that the Fc
binding capacity was mediated by a protein of approxi-
mately 65kDa size, and N-terminal sequencing of this pro-
tein demonstrates its identity with the heat shock
response protein GroEL. Western blotting of B. henselae
cellular fractions indicates that GroEL was located in the
cytoplasm and in the inner and outer membrane of the
cell, as previously demonstrated for B. bacilliformis [59].
Expression of recombinant B. henselae GroEL conferred
an Fc binding capacity on Escherichia coli (Figure 5). A
further mechanism by which bartonellae may counteract
the threat of host immunity is via lipopolysaccharide
(LPS) modification. The LPS of B. henselae possesses an
unusual penta-acylated lipid A with a longchain fatty acid
[61], a modification that may attenuate toll-like receptorls and erythrocytes. Exploitation of vascular endothelial cells by
s well as VirB/D4 and possible other adhesions as Omp43/pap31. VirB/
ton, resulting in the formation of large bacterial aggregates by the
endothelial cell survival. The mechanisms of the passage of Bartonella
that before infecting erythrocytes, the bacteria is free in the blood.
nella species) or by flagella (for B. bacilliformis and the lineage 2
e inside, replicates in a membrane-bound compartment then persists














WT B. birtlesii 
WT B. birltesii+ anti-badA/100
badA B. birtlesii







Figure 4 Role of B. birtlesii BadA in complement inactivation. (A) Wild type (WT) and a badA-knockout mutant (ΔbadA) of B. birtlesii were
incubated with foetal calf serum at 35°C in a 5% CO2 atmosphere for one hour then plated onto Columbia blood agar plates. Plates were
incubated at 35°C in a 5% CO2 atmosphere for 5 days then colony forming units were counted. N = 6 +/− SE. (B) As described in (A) except that
foetal calf serum was heated at 56°C for 30 min to inactivate the complement prior to use. N = 6 +/− SE.
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[61,62].
Step 3: Erythrocyte encounter and adhesion
The ability of bartonellae to exploit erythrocytes is key
to their parasitic strategy and is almost unique amongst
bacteria. Once inside erythrocytes, bartonellae occupy an
immunologically privileged niche that, by virtue of its
position in the circulatory system, facilitates not only
persistence within the reservoir host but also uptake by
haematophagous vectors.
There is, as yet, no evidence that Bartonella species
are able to sense and specifically move towards circulat-
ing erythrocytes, hence we must currently assume that
contact between bacterium and erythrocyte results from
their chance encounter. Some Bartonella species possess
flagella, which may facilitate their movement in blood
plasma, but their absence from most species suggests
they are not essential appendages and indeed, there is
evidence that their value in host interaction occurs else-
where during the course of infection (see below).
Adherence to erythrocytes by most Bartonella species
appears to be mediated by the Trw T4SS and as yet
uncharacterised receptors. Trw is the third T4SS found
in bartonellae, and its importance in the establishment
of intra-erythrocytic infections by bartonellae in reser-
voir hosts has been recognised for some time [63-65].
However, evidence for the direct role of Trw in erythro-
cyte infection has been only recently obtained following
the development of an in vitro model for erythrocyte ad-
herence and invasion [19]. In this study, we identified B.birtlesii genes required for erythrocyte infection by iden-
tifying, among STM mutants unable to induce bacter-
aemia in mice, those which could also not invade
erythrocytes in vitro. From this screening, we identified
nine invasion-deficient mutants. In seven of these, genes
within the trw operon were disrupted, whereas in the
other two, disruptions were located in the invasion-
associated ialA/B locus (see below) and in livG, a puta-
tive ABC-transporter encoding gene. The nature of our
screening resulted in the conclusion that the products of
all these genes were essential for the adhesion to and/or
invasion of erythrocytes rather than replication or per-
sistence within them.
Trw shares homology with the broad-host-range con-
jugation system of R388 plasmid and was acquired by
ancestral bartonellae via horizontal genetic transfer from
phylogenetically distant bacterial species [66]. Unlike
VirB/D4, the Trw T4SS lacks the coupling protein
required for export of effectors, suggesting that it is no
longer a secretion system [65]. The trw genes of Barto-
nella species are co-linear with the respective genes of
plasmid R388 except for the presence of multiple tan-
dem gene duplications of trwL (the virB2 homolog) and
trwJ-I-H (the virB5, virB6 and virB7 homologs). The
multiple copies of trwL and trwJ are thought to encode
the suface-exposed pilus components of the T4SS, while
the products of trwI and trwH are thought to be
involved in pilus elongation and anchorage of the T4SS
to the outer membrane (Figure 2). The presence of the
multiple copies of these components indicates that they
probably participate in the expression of variant pilus
Figure 5 Far-Western blot of E. coli BL21 (1), E. coli BL21
transformed with pET30a (Novagen) (2), and E. coli BL21
transformed with pET30-AR1 (3) (see below), probed with rat Fc
fragments conjugated to alkaline phosphatase (Jackson
Immunoresearch). All strains were grown in LB to log-phase and
induction of plasmid expression was achieved using IPTG as per the
manufacturer’s instructions (Novagen). Construction of pET30a-AR1:
The B. henselae groEL ORF was amplified using a PCR incorporating
primers BhgroELF (AAG GAG AGG AAG AAA TGG CTG CTA AAG AAG
T) and BhgroELR (TCA AGG GCT TAG AAA TCC) then cloned into
pCR2.1-TOPO and used to transform E. coli TOP10 cells according to
the manufacturer’s instructions (Invitrogen). The resulting plasmid,
pAR1-TOPO, was purified then digested with BamHI and XhoI to
yield a 1600 bp fragment that included the groEL ORF. This fragment
was cloned into compatible sites of pET30a (Novagen) to generate
pET30-AR1, which was used to transform E. coli XL10 cells
(Stratagene). pET30-AR1 was recovered from these cells and
subcloned into E. coli BL21 cells.
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and thus if numerous pili variants are concurrently
present in the bartonellae population infecting a host or
if differential expression of copies of these genes occurs,
resulting in different pili variants being present on the
bacterial cell surface during different stages of the infec-
tion process. It has been hypothesised that the presence
of pili variants may facilitate the interaction with differ-
ent erythrocyte receptors or with the variable forms of a
specific receptor found across the breadth of the reser-
voir host population [64,67].
Our studies have also yielded evidence that Trw is a
key determinant of bartonellae host specificity. As dis-
cussed above, although bartonellae can infect non-
reservoir hosts, when they do so they are unable to es-
tablish an intra-erythrocytic bacteraemia. However, wewere able to confer on B. henselae and B. quintana
(which are naturally associated with only cats or humans
respectively) the ability to interact with rat erythrocytes
by transforming them to express the trw locus of the
rat-adapted species B. tribocorum [19].
Even though erythrocyte parasitism is the hallmark of
Bartonella species, the trw genes are not present in all
Bartonella species, but are restricted to members of
lineage 3 with the exception of this lineage’s outlier, B.
clarridgeiae (Figure 1). This distribution suggests that
the Trw T4SS was horizontally acquired by a common
ancestor of these members of lineage 3 [4]. Interestingly,
the distribution of Trw and flagella among the Barto-
nella species is mutually exclusive (Figure 1), thus it has
been proposed that following its acquisition, the func-
tion of Trw evolved to replace that performed by fla-
gella. This hypothesis is supported by observations that
the flagella of B. bacilliformis are involved in adhesion to
and entry of erythrocytes [68-70].
Step 4: Invasion of and persistence within
erythrocytes
Among the first virulence factors to be described for bar-
tonellae were those encoded by the ialA/B locus in B.
bacilliformis [71,72]. The survey of B. birtlesii genes
involved in erythrocyte adherence/invasion, described
above, also identified ialA and ialB. Early work demon-
strated that the transformation of E. coli with B. bacillifor-
mis ialA/B conferred the ability to invade erythrocytes
[71] and more recently, we have shown that although dele-
tion of ialB did not significantly affect adhesion of B. bir-
tlesii to erythrocytes, it provoked a 10 fold decrease in
bacterial entry into erythrocytes [19]. IalA has been char-
acterized as a (de)nucleoside polyphosphate hydrolase of
the MutT motif family and has homologs in other invasive
bacteria such as Yersinia enterocolitica and Rickettsia pro-
wazekii [73]. The precise role of IalA and its homologs is
suspected to be the reduction of stress-induced dinucleo-
tide levels during invasion, thereby enhancing pathogen
survival [73]. IalB is a 19.9 kDa protein with about 64% se-
quence similarity to the Yersinia enterocolitica protein Ail,
a surface protein that plays a key role in mediating cell
entry and serum resistance [60]. Intriguingly, B. bacillifor-
mis IalB appears to be localised in the inner membrane
[71] so it is unclear how it affects its role in erythrocyte
entry. However, more recent work has suggested that in B.
henselae, the protein is also associated with the outer
membrane [72,74]. To add to this uncertainty, we have
been able to detect IalB in B. birtlesii cryo-sections but
not in intact bacteria, supporting the hypothesis that this
protein is not surface exposed (Figure 6). Exploration of
the determinants of ialB expression in B. bacilliformis has
been reported and the patterns of expression observed
under different conditions (temperature, pH, oxidative
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lated in response to environmental cues signalling passage
of the bacterium from the vector to the host, and also
possibly at times when the bacterium is subjected to
stress-inducing environmental conditions [75]. Despite the
identification of entry-associated virulence factors, we cur-
rently have very little idea about how bartonellae enter
erythrocytes. Given the unusual structure and physiology
of erythrocytes, it is likely that bartonellae employ a mech-
anism of invasion that is different from those used for
microbial entry into other cell types. How akin this mech-
anism is to, for example, those employed by Plasmodium
species for erythrocyte invasion, remains to be seen. Mi-
croscopy has been used to monitor B. bacilliformis entry
into erythrocytes, suggesting that the bacteria provoke
then enter substantial deformations in erythrocyte mem-
branes [68]. In this study, bacteria appeared to drive them-
selves into deep invaginations in the red cell surface, then
membrane fusion at the necks of these invaginations led
to the formation of intracellular vacuoles containing bac-
teria [68]. This process was considered, at least in part, to
be mediated by the action of flagella. As discussed above,
only very few Bartonella species express flagella, hence
those without these appendages must have evolved an
alternative entry strategy. There is also evidence that
bartonellae produce an extracellular protein, termedFigure 6 Localisation of IalB in B. birtlesii cells using immunogold sta
birtlesii antiserum (A), negative serum (B), and B. birtlesii recombinant IalB a
localise IalB in cryosections of B. birtlesii cells. Arrows indicate the position odeformation factor, which induces extensive invaginations,
dentations and trenches in erythrocyte membranes
[76,77].
Intra-erythrocytic replication starts within a vacuolar
membrane immediately after invasion [3]. After several
days, bacterial replication stops so that the number of
intracellular bartonellae remains unchanged for the
remaining life span of the erythrocyte. Within the red
blood cell, bartonellae must not only scavenge for nutri-
ents and also counter oxidative stress. Genomics has iden-
tified potential candidates that may be involved in these
processes; proteases IalA and CtpA degrade misfolded
proteins that arise from stress, and the genes encoding
these proteins have been shown to be essential for the
establishment of bacteraemia [4,19]. As yet, none of the
molecular mechanisms underlying or regulating multipli-
cation, growth control and then persistence of Bartonella
species within erythrocytes have been identified.
Akin to many pathogenic bacteria, bartonellae utilizes
host haem-containing proteins as a source of haem and
iron. It has been shown that Bartonella species use a
paralogous gene family of haem binding proteins (Hbps)
and a haem uptake locus to sequester haem [78-80]. We
have previously shown that B. birtlesii and B. tribocorum
strains in which the genes encoding Hbps had been dis-
rupted were unable to induce bacteraemia in theirining. Primary antisera used on intact bacteria were whole cell B.
ntiserum (C). In (D) B. birtlesii recombinant IalB antiserum was used to
f immunogold labels in these images.
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of these proteins in host exploitation by Bartonella
species [4,19]. Both the hbp genes and the haemin-
associated locus (hut) are regulated by Irr, a regulatory
protein involved in response to various stimuli including
temperature shift, oxygen level and haemin concentra-
tion [81,82]. Further studies of those systems will con-
tribute to our understanding of how bartonellae use the
most abundant source of haem in the mammalian host,
haemoglobin, and this contributes to its persistence
within erythrocytes.
The rapid development of transcriptomic technologies
should soon provide the means for exploration of the
dynamics of bacterial gene expression during host inter-
action, thus we predict that the transcriptome of intra-
erythrocytic bartonellae will soon be available, helping
us better understand the molecular means by which bar-
tonellae thrive in their erythrocyte niche.
There is currently no evidence to suggest that infec-
tion of erythrocytes by Bartonella spp. has a significant
effect on their physiology (life span and membrane in-
tegrity appear unchanged) [3]. However some subtle
changes may occur; for example, during the period of
erythrocyte invasion and multiplication, B. tribocorum-
infected cells are cleared from circulation more rapidly
than uninfected cells. However, once intracellular repli-
cation has ceased, this difference in clearance rates dis-
appears [3]. These observations suggest that there are
“recognizable” changes in erythrocyte structure or physi-
ology during the early stages of their parasitism. These
changes may result from the effects of deformin, as dis-
cussed above, with altered erythrocytes being filtered out
by the spleen as demonstrated for Plasmodium spp. [83].
While most Bartonella species appear intent on not
significantly altering the physiology of the circulating
erythrocyte population, B. bacilliformis has the potential
to provoke severe haemolytic anemia [84], although this
pathology is not necessarily a consequence of infection.
Evidence that haemolysis may be mediated by a contact-
dependant haemolysin has been presented [84], but this
protein has yet to be fully characterized. Interestingly, al-
though putative haemolysin-encoding genes are present
in the B. bacilliformis genome, they are also found in the
genomes of other Bartonella species.
Conclusion
The high prevalence of infections in mammals, and the
potential threat posed to the health of humans, livestock
and companion animals, warrants further exploration of
the fundamental biology of Bartonella species. Despite a
huge effort in the last 20 years to understand the
mechanisms used by bartonellae to exploit their natural
reservoir hosts, many areas of uncertainty remain and
require further research.In retrospect, one of the key studies that paved the way
for recent advances was that completed a decade ago de-
scribing the dynamics of”natural” infection, as monitored
using fluorescently-labelled bacteria [3]. The identification
and quantification of distinct stages of infection, in
tandem with the development of reliable tools for the gen-
etic manipulation of bartonellae, has allowed significant
advances to be made in our understanding of the molecu-
lar basis of bartonellae parasitism. However, despite this
progress, and the ever increasing medical importance of
bartonellae, it appears that today fewer and fewer scien-
tists are studying these bacteria. It is unthinkable that
research into the molecular basis of bartonellae-host inter-
actions should falter now, with so many important and ex-
citing questions still to be answered. For example, what is
the fate of bacteria following inoculation? How do bacteria
disseminate around the body and is the endothelial vascu-
lature truly a primary niche for infection? Furthermore,
why, on occasion, do bartonellae provoke angiogenesis?
We also know nothing about how bartonellae regulate
their intra-erythrocytic replication and persistence, what
physiological changes they endure. We know little about
the interaction between bartonellae and host immunity
and thus little about the extent and importance of immu-
noregulation. Researchers also need to consider the role of
arthropods in the bartonellae natural cycle and should
perhaps incorporate “natural” inoculation by arthropods
rather than by syringe into relevant animal models. In
summary, the challenges for future years, are (1) to under-
stand how, the unique infection strategy of bartonellae
contributes to their remarkable epidemiological success in
their reservoir hosts, and (2) to better assess if bartonellae
have the potential to emerge as new zoonotic pathogens.
In such a small field, a constructive means of helping to
invigorate stimulating and high level science is collabor-
ation between those laboratories with expertise in various
key technical skills (experimental vector transmission,
genetics, animal models) and those with the enthusiasm,
but perhaps not all the means, to progress the field. Such
initiatives should be encouraged and welcomed by all.Competing interests
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